Growblox Sciences Inc. GBLX Archives

FridayJun 26, 2015 8:49 am

GrowBLOX Sciences (GBLX) Seeks Preferred Provider Status in Booming Medical Marijuana Market

The State of Nevada is in high anticipation about its upcoming 2016 general election ballot initiative that proposes legalizing recreational use of marijuana. With Colorado’s $700 million wind-fall last year and trending to break $1 billion in annual revenues by 2016, the medical marijuana (MMJ) market in Nevada could very quickly get a whole lot bigger next year. Poised and positioned to capitalize on this upcoming opportunity is GrowBLOX Sciences (OTC:GBLX). The company has advanced cultivation technology systems that ensure genetic potential of propagated strains that possess more active ingredients per pound than is achieved with any other cultivation method.…

MondayJun 22, 2015 12:30 pm

GrowBLOX Sciences, Inc. (GBLX) Moving to Meet Burgeoning Cannabis Demand via Multi-Channel Distribution Approach

With the race now officially on to open the first medical marijuana (MMJ) dispensaries in Nevada, just a month after Nevada Pure broke ground on the state's first big secure farming operation in east Las Vegas, anticipation is running high across the state regarding the upcoming 2016 general election ballot initiative that may legalize recreational use. Given that Colorado pulled in over $700 million last year and is currently on track to break $1 billion in annual revenues by 2016, according to projections based on state Department of Revenue data, and that a poll back in 2013 already showed 54…

MondayJun 15, 2015 10:27 am

GrowBLOX Sciences, Inc. (GBLX) Signs Financing, Licensing Agreements for Advancement in Nevada Cannabis Market

GrowBLOX Sciences has entered into a Note Purchase Agreement with Pacific Leaf Ventures, LP in which Pacific Leaf has agreed to make an installment loan to GrowBLOX of up to $1.75 million. According to an SEC filing, the financing provides the funding for GrowBLOX subsidiary GB Sciences Nevada, LLC to acquire and install an operating facility, equipment, and other tangible assets for the cultivation of cannabis and the extraction of oils and other constituents present in cannabis, in adherence to Nevada legal requirements. GBS Nevada holds a provisional certificate from the Division of Public & Behavioral Health of the Nevada…

MondayJun 08, 2015 3:31 pm

A Full-Spectrum Approach to the Medical Cannabis Industry is grounded in Data-Driven Cultivation & Drug Development

With news in just last week that the Republican-controlled House of the Texas Legislature has approved cannabis oil for medicinal purposes, as the passage of Senate Bill 339, known as the “Texas Compassionate Use Act,” means Governor Greg Abbott is now within striking distance of allowing dispensing organizations to obtain a license to dispense low-THC cannabis in the state, the medical marijuana industry is once again buzzing about the upper limit potential of this sector. Passage of SB 339 would make Texas the latest addition to a growing list of states in the U.S. passing similar landmark medical marijuana (MMJ)…

MondayJun 01, 2015 6:22 pm

A Full-Spectrum Approach to the Medical Cannabis Industry is Grounded in Data-Driven Cultivation & Drug Development

TuesdayMay 26, 2015 12:14 pm

GROWBlox Sciences, Inc.’s (GBLX) Advantageous Approach to Medical Cannabis Highlighted at CannabisFN

CannabisFN this morning highlighted GROWBlox Sciences’ role in the cannabis and pharmaceutical industries, paying particular attention to the company’s “unique business model, long-term potential in pharmaceuticals, and short-term potential in raw material sales.” Read the full report here: http://www.marketwatch.com/story/growblox-sciences-takes-integrated-approach-to-cannabis-medicine-2015-05-25?page=1 Twenty three U.S. states and the District of Columbia have legalized marijuana, and according to IBISWorld estimates, broader acceptance of cannabinoid-based therapies throughout the U.S. has spurred the medical cannabis industry’s CAGR of 16.2% to reach $2 billion in revenue between 2009 and 2014. As CannabisFN points out, GROWBlox Sciences stands out from numerous would-be competitors in the industry with its…

FridayMay 15, 2015 11:25 am

Growblox Sciences, Inc. (GBLX) Prepares for Commercialization through Launch of New Subsidiary

Growblox Sciences earlier this week took a step toward the commercialization of its GrowBLOX™ technology suite through the establishment of Growblox Sciences Puerto Rico, LLC (GBS PR), a majority-owned subsidiary housed on the Caribbean commonwealth. The move comes on the heels of an executive order issued last Sunday by Governor Alejandro Garcia Padilla authorizing the use of some or all controlled substances or derivatives of the cannabis plant for medical use. Through a collaboration with GrowBlox the island is now launching a clinical investigation into the use and production of medicinal cannabis. “We are very excited by the timing of…

ThursdayMay 14, 2015 11:18 am

GrowBLOX Sciences, Inc. (GBLX) is “One to Watch”

GrowBLOX Sciences, a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country. The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant's life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water,…

WednesdayMay 13, 2015 8:05 am

Growblox Sciences (GBLX) Announces Commercialization Initiative and Financing

Growblox Sciences, a biopharmaceutical research and development company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today it has established Growblox Sciences Puerto Rico, LLC ("GBS PR"), a majority-owned subsidiary domiciled in Puerto Rico. "As widely reported, Puerto Rico Governor Alejandro Garcia Padilla recently signed an executive order authorizing the production of medical cannabis. We are very excited by the timing of this announcement as it coincides with our continuing presence in Puerto Rico and our commitment to realizing significant fundamental growth this fiscal year." Stated Growblox Sciences' CEO & Chairman Craig Ellins.…

TuesdayMay 12, 2015 8:58 am

Growblox Sciences, Inc. (GBLX) Updates Communication Strategy with Launch of New Corporate Website

Growblox Sciences, a biopharmaceutical research and development company focused on the production of consistent medicinal cannabis, announced on Monday the launch of its new corporate website. “We have navigated many obstacles in the process of refining our vision and gathering a complete understanding of the medicinal cannabis landscape,” stated Craig Ellins, the company’s Chief Executive Officer. “Growblox is here to cultivate an industry, not just a plant.” The medicinal cannabis industry is continuing to expand, particularly in the United States. In addition to four states and Washington D.C. moving to legalize recreational use of cannabis in recent months, 19 states…

Site Search

Company Search

Tag: Growblox Sciences Inc. GBLX